A significant predictor of in-hospital and long-term mortality and progression in COVID-19 patients: The end-stage liver disease (MELD) score modelArticle Published on 2023-01-012023-06-20 Journal: Journal of medical virology [Category] Fulltext, MERS, [키워드] COVID-19 in-hospital mortality intensive care unit admission. [DOI] 10.1002/jmv.28109 PMC 바로가기
The value of EEG attenuation in the prediction of outcome in COVID-19 patientsArticle Published on 2022-11-012022-11-16 Journal: Neurological Sciences [Category] SARS, 유전자 메커니즘, [키워드] biomarkers of inflammation Brain imaging brain involvement Cohort collected consecutive patients correlated correlation COVID-19 pandemic COVID-19 patient COVID-19 patients EEG EEG attenuation EEG background EEG suppression Encephalopathy epileptiform evaluated heterogeneous Hypoxemia identify in-hospital mortality lesion mechanism non-survivor Non-survivors Occurrence Organ failure outcome PaO patients performed Prevalence prevalent Prognosis recorded reduced reported SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2. significantly significantly lower suppressed [DOI] 10.1007/s10072-022-06354-8 PMC 바로가기
A comparative analysis of the outcomes of patients with influenza or COVID-19 in a tertiary hospital in BelgiumResearch article Published on 2022-11-012022-10-05 Journal: Journal of infection and chemotherapy : official j [Category] 진단, 치료기술, [키워드] Admission Analysis bacterial superinfection Belgium cardiovascular complication cohort study COVID-19 COVID-19 pandemic COVID-19 patient died difference ECMO Health hospital hospitalized patient ICU ICU admission in-hospital mortality increased risk Influenza influenza infection intensive care Intubation rates morbidity and mortality Mortality outcome Outcome comparison Patient patients with COVID-19 patients with influenza Propensity score matched analysis readmission required Result retrospective Seasonal influenza secondary severity single-center with COVID-19 [DOI] 10.1016/j.jiac.2022.07.012 [Article Type] Research article
Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infectionResearch article Published on 2022-11-012022-10-05 Journal: Multiple sclerosis and related disorders [Category] 진단, [키워드] adjusted Admission admitted to ICU association Clinical outcome COVID-19 cross-sectional diagnosis of COVID-19 Disease-modifying therapies Electronic health record General population health systems Healthcare provider Hospital admission Hospitalization Hospitalized ICU immunomodulatory immunosuppressive in-hospital mortality increased risk Infection Iran Mortality mortality risk multiple sclerosis outcome Patient patients with COVID-19 PCR Result risk risk factor Severe COVID-19 Infection severity therapy vaccinated against COVID-19 were recorded [DOI] 10.1016/j.msard.2022.104067 [Article Type] Research article
Multi-inflammatory Index as a Novel Mortality Predictor in Critically Ill COVID-19 PatientsArticle Published on 2022-11-012022-11-15 Journal: Journal of Intensive Care Medicine [Category] 바이오마커, [키워드] Analysis analyzed Biomarker C-reactive protein Combination coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient CRP dead Efficacy group help ICU Ill in-hospital mortality index Inflammation inflammatory parameter inflammatory parameters intensive care intensive care unit investigated lymphocyte median age medical record Mortality multi-inflammatory index. multiple logistic regression NLR Non-survivors novel Pathogenesis patients significantly higher survived survivor systemic systemic inflammation two group [DOI] 10.1177/08850666221100411 PMC 바로가기
Evaluation of Procalcitonin’s Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 PatientsArticle Published on 2022-11-012022-11-15 Journal: Journal of Intensive Care Medicine [Category] 바이오마커, [키워드] Antibiotic therapy AUC Bacteremia Bacterial Bacterial infection bacterial pneumonia baseline characteristics Concomitant conducted COVID-19 creatinine Critical Critical illness Critically ill patient Culture defined determine diagnosing diagnostic ENhance evaluate group hospitalized patients ICU ICU patient identify Ill in-hospital mortality intensive care intensive care unit Mortality multivariable multivariable model no difference no significant difference offer outcome Patient PCT Pneumonia positive predict Predictive procalcitonin procalcitonin. receiver operating characteristics Regression model retrospective cohort study ROC SARS-CoV-2 secondary bacterial pneumonia serum creatinine Severe COVID-19 pneumonia Severity of disease specificity threshold utility variable vital signs was used while with COVID-19 [DOI] 10.1177/08850666221108636 PMC 바로가기
Comparative epidemiology of five waves of COVID-19 in Mexico, March 2020-August 2022Article Published on 2022-10-312022-11-16 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI age analyzed Antigen association average calculated Care case fatality rates Comorbidities Comparative confirmed case confirmed cases COVID-19 COVID-19 case Critical death declined decrease Demographic factors Epidemic epidemic wave epidemiological Epidemiology estimates Factors Fatality rate FIVE Gender Health highest hospital Hospital admission Hospitalization hospitalizations Hospitalized In-hospital In-hospital death in-hospital mortality incidence increase in individual Intubated intubation intubations laboratory-confirmed male Metrics notable omicron pandemic Patient patients with comorbidities recorded reduction in Regression model risk SARS-CoV-2 SARS-CoV-2. second wave security severe disease severity subsequent Surveillance symptoms onset System vaccination variant were recorded [DOI] 10.1186/s12879-022-07800-w PMC 바로가기
Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitalsArticle Published on 2022-10-272022-11-16 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] Acute respiratory infection adjusted adjusted odds ratio age analysed analysis applied B.1.1.529 B.1.617.2 Characteristics characterized Cohort Comorbidity Course COVID-19 COVID-19 case COVID-19 patient defined Delta described difference disease severity dominant variant exceeded female Gender Germany Helio hospital In-hospital in-hospital mortality Infection infections Infectious disease Inpatient intensive care treatment mechanical ventilation omicron outcome outcomes pandemic Patient reduced Regression risk SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants significantly lower stratified Surveillance variant virus [DOI] 10.1186/s12879-022-07781-w PMC 바로가기
Association of Interleukin-17F Polymorphism and Mortality Predictors with the Risk of COVID-19Article Published on 2022-10-272022-11-15 Journal: International journal of clinical practice [Category] 변종, 진단, [키워드] age allele Analysis association AUC case-control study CD4 cells Characteristics control subject controls Coronavirus disease-19 COVID-19 COVID-19 infection COVID-19 mortality COVID-19 patient COVID-19 patients cutoff point D-dimer death determine enzyme-linked immunosorbent exhibiting expression Genotype genotyping healthy higher odd hypertension IL-17 immunological injuries in-hospital mortality independent predictor investigated Laboratory no significant difference non-survivor outcome participant polymorphism predictor proinflammatory risk of COVID-19 ROC Curve subset suggested survivor susceptibility T lymphocytes tested variant WBC White blood cell with COVID-19 [DOI] 10.1155/2022/4761631 PMC 바로가기
Real-world effectiveness of steroids in severe COVID-19: a retrospective cohort studyArticle Published on 2022-10-052022-11-16 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] age analysed association clinical co-morbidity Cohort confounder Controlled trial Coronavirus disease 2019 COVID-19 defined Dexamethasone disease Effectiveness EPR Gender hazard hospital Hydrocortisone hypoxia in-hospital mortality individual Methylprednisolone Mortality multivariable multivariate model outcome Patient positive patient Prednisolone protective effect randomised clinical trial reduce replicate replicated reported retrospective cohort study Retrospective study risk SARS-CoV-2 RNA SARS-CoV-2 variant severe COVID-19 shown steroid steroid treatment steroids. treated Treatment viral genome was measured [DOI] 10.1186/s12879-022-07750-3 PMC 바로가기